A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
This publication has 58 references indexed in Scilit:
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan CriteriaAnnals of Surgery, 2011
- Postoperative transcatheter arterial chemoembolization should be recommended in the hepatocellular carcinoma treatment guidelines of the American Association for the Study of Liver DiseasesHepatology, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta‐analysisHepatology Research, 2010
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Postoperative Transhepatic Arterial Chemoembolization and Portal Vein Chemotherapy for Patients with Hepatocellular Carcinoma: A Randomized Study with 131 CasesDigestive Surgery, 2006
- Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomyJournal of Cancer Research and Clinical Oncology, 1995